SP0454, a putative threonine dehydratase, is required for pneumococcal virulence in mice

WenJuan Yan1, Hong Wang, WenChun Xu

  • 1Laboratory Medicine College, Key Laboratory of Diagnostic Medicine designated by the Ministry of Education, Chongqing Medical University, Chongqing, 400016, P. R. China.

Insights

Investigating Streptococcus pneumoniae virulence factors is key for new vaccines and antibiotics. Inactivating the sp0454 gene reduced bacterial colonization and virulence in mice, suggesting its role in pneumococcal infection.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Antibiotic resistance and the need for novel vaccines necessitate understanding pneumococcal virulence.
  • Identifying key factors in Streptococcus pneumoniae pathogenesis is crucial for therapeutic and preventative strategies.

Purpose of the Study:

  • To investigate the role of the putative threonine dehydratase sp0454 in Streptococcus pneumoniae virulence.
  • To determine the impact of sp0454 inactivation on bacterial adherence, colonization, and pathogenicity in a murine model.

Main Methods:

  • Gene inactivation of sp0454 in Streptococcus pneumoniae CMCC 31203 using erythromycin-resistance cassette replacement.
  • Assessment of mutant phenotypes including cell growth, adherence to A549 cells, colonization, and virulence in a murine intranasal infection model.
  • Real-time RT-PCR analysis to evaluate the expression of pneumococcal surface antigen A (psaA).

Main Results:

  • The Δsp0454 mutant exhibited reduced colonization ability and impaired adherence to A549 cells compared to the wild-type strain.
  • The sp0454 deletion mutant demonstrated decreased virulence in the murine intranasal infection model.
  • Real-time RT-PCR revealed a significant downregulation of psaA expression in the sp0454 mutant.

Conclusions:

  • The SP0454 protein contributes to the virulence and colonization capabilities of Streptococcus pneumoniae.
  • SP0454 may exert its effects partly by modulating the expression of other virulence factors, such as psaA.
  • Targeting sp0454 could be a potential strategy for developing new interventions against pneumococcal infections.